Anticoagulation is a critical component in the treatment of cardiovascular diseases. Large randomised controlled trials have demonstrated that direct oral anticoagulants (DOACs) are effective and safe ...
Merck Animal Health shared earlier this week that the FDA approved its atinvicitinib tablets (NUMELVI; Merck Animal Health), a once daily, first line treatment for canine patients 6 months and older ...